Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum

Rhea-AI Summary

Miromatrix Medical Inc. is set to present its pioneering bioengineering technology at the Bioregate European Regenerative Medicine Forum from September 21-23, 2022, in Louvain-la-Neuve, Belgium. CEO Jeff Ross will deliver the keynote speech on September 21 at 3:05 pm CEST. The event focuses on the themes of repair, replacement, regeneration, and reprogramming in regenerative medicine, organized by several prestigious universities and organizations. Miromatrix aims to address the shortage of transplantable human organs, focusing on liver and kidney bioengineering.

EDEN PRAIRIE, Minn., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced CEO Jeff Ross will present at the Bioregate European Regenerative Medicine Forum. The conference, held this year on September 21-23 in Louvain-la-Neuve, Belgium, is dedicated to the 4R Medicine, Repair, Replacement, Regeneration, and Reprogramming.

Mr. Ross will be a keynote speaker at the Bioregate European Regenerative Medicine Forum on September 21^st, 2022 at 3:05 pm CEST.         

The event is organized by Nantes University, the Catholic University of Louvain and Atlanpole Biotherapies, with the support of the University of Liège, FlandersBio, BioWin, Wallonie-Bruxelles International, FNRS, the Region of Pays de la Loire and Nantes Métropole.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

What is Miromatrix Medical presenting at the Bioregate European Regenerative Medicine Forum in 2022?

Miromatrix Medical Inc. will present its bioengineering technology for transplantable organs at the Bioregate European Regenerative Medicine Forum.

When is Jeff Ross speaking at the Bioregate European Regenerative Medicine Forum?

Jeff Ross will speak on September 21, 2022, at 3:05 pm CEST.

What are the main themes of the Bioregate European Regenerative Medicine Forum?

The forum focuses on 4R Medicine: Repair, Replacement, Regeneration, and Reprogramming.

Where is the Bioregate European Regenerative Medicine Forum being held in 2022?

The forum is held in Louvain-la-Neuve, Belgium.

What organ types is Miromatrix Medical focused on bioengineering?

Miromatrix is primarily focused on bioengineering human livers and kidneys.